Alan Faraj

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Atrial Fibrillation

Randomized Controlled Trial

Top Venues

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Alan Faraj, Joakim Nyberg, Grant E Blouse, Tom Knudsen, Ulrika S H Simonsson
Subcutaneous Marzeptacog Alfa (Activated) for On-Demand Treatment of Bleeding Events in Subjects With Hemophilia A or B With Inhibitors. Clinical pharmacology and therapeutics (2024)
Alan Faraj, Joakim Nyberg, Grant E Blouse, Tom Knudsen, Ulrika S H Simonsson
Subcutaneous Marzeptacog Alfa (Activated) for On-Demand Treatment of Bleeding Events in Subjects With Hemophilia A or B With Inhibitors. Clinical pharmacology and therapeutics 115 (3) (2024)
Alan Faraj, Joakim Nyberg, Grant E Blouse, Tom Knudsen, Ulrika S H Simonsson
Subcutaneous Marzeptacog Alfa (Activated) for On-Demand Treatment of Bleeding Events in Subjects With Hemophilia A or B With Inhibitors. Clinical pharmacology and therapeutics 115 (3) (2024)
Alan Faraj, Joakim Nyberg, Grant E Blouse, Tom Knudsen, Ulrika S H Simonsson
Subcutaneous Marzeptacog Alfa (Activated) for On-Demand Treatment of Bleeding Events in Subjects With Hemophilia A or B With Inhibitors. Clinical pharmacology and therapeutics 115 (3) (2024)